可定制的氨酸平台使叶酸受体PET成像使用铜-64实现
Hailey A Houson1, Zhiyuan Wu2, Phuong-Lien Doan Cao3
1Department of Radiology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294, United States.
Molecular pharmaceutics
|April 16, 2024
概括
一种新型的放射性追踪剂,Cu-O5,准在卵巢癌中过度表达的叶酸受体α (FRα). 这种化合物在临床前模型中显示出高瘤吸收和核转位,为改善癌症成像提供了潜在的潜力.
科学领域:
- 在瘤学瘤学.
- 放射化学 放射化学是指辐射化学.
- 分子成像学分子成像学
背景情况:
- 叶酸受体α (FRα) 在许多卵巢癌中过度表达,与耐药性和不良预后相关.
- 针对FRα阳性癌症的向治疗和成像剂对于改善患者的治疗结果至关重要.
研究的目的:
- 开发和描述一种新型的放射性追踪器,[64Cu]Cu-O5,用于向卵巢癌中的FRα.
- 评估[64Cu]Cu-O5在FRα阳性瘤成像中的体外和体内性能.
主要方法:
- 合成和放射性标记的化合物O5与铜-64 (Cu).
- 在FRα阳性IGROV1细胞和亚细胞分离中的细胞吸收实验室研究.
- 在IGROV1异种移植的小鼠体内正子发射断层扫描 (PET) 成像.
主要成果:
- [64Cu]Cu-O5在合成时具有较高的摩尔活性,并且在人血清中表现出稳定性.
- 在FRα阳性细胞中观察到高特异性[64Cu]Cu-O5的吸收,与细胞质和核分数有显著的关联.
- 在异种移植模型中,PET成像显示了瘤明显吸收[64Cu]Cu-O5,肝脏积累最小,瘤与背景比率高.
结论:
- [64]Cu-O5是一种有前途的FRα向放射追踪器,具有用于卵巢癌成像的有利临床前特征.
- 观察到的高细胞吸收和瘤向表明在诊断和监测FRα表达性癌症方面具有临床翻译的潜力.
相关概念视频
Positron Emission Tomography
4.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.2K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
112
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
112

![Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F55537.jpg&w=3840&q=50)
